A British pharmaceutical company, CM&D Pharma has come up with a new innovative chewing gum that could help kidney disease sufferers. Food giant Nestle has bought this firm for an undisclosed amount which was previously backed by Inventages Group. This takeover is just a month after Nestle launched its 'Nestle Health Science Division' which specializes in science based nutritional treatments. The company aims on developing products for dietary management of widespread conditions and chronic problems.
Fostrap, another product by the CM&D Pharma helps kidney disease patients by removing high levels of phosphate collected in their saliva. Its other products include colon protector- for prevention of colon cancer and a product for intestinal pain.
AdvertisementPresident and chief executive of Nestle Health Science, Mr. Luis Cantarell, said, "This acquisition is an excellent fit with Nestle Health Sciences strategic goal of being a pioneer in the promising area of science-based nutrition."